Concepedia

Vittorina Zagonel

VZ

Statistics

Publications

302

Citations

24.7K

H-Index

72

Active since

1982

Affiliations

Istituto Oncologico Veneto(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Padua

Centro di Riferimento Oncologico

Azienda Ospedaliera Universitaria Pisana

Vittorina Zagonel is an author at Istituto Oncologico Veneto specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1982–2024

302

Publications

302

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu, Richard S. Finn, Julien Edeline et al. · The Lancet Oncology · 2018 · 2.5K citations

, , +11

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text

, , +16

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

Fotios Loupakis, Chiara Cremolini, Gianluca Masi et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

, , +12

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino et al. · The Lancet Oncology · 2016 · 1K citations · Full text

, , +14

ALK+ lymphoma: clinico-pathological findings and outcome.

Brunangelo Falini, Stefano Pileri, Pier Luigi Zinzani et al. · PubMed · 1999 · 567 citations

, , +12

1–5 of 302